ARCHIVES

Investigator Initiated Clinical Research Gets More For Less Money, Carbone Contends

This article is from The Cancer Letter archive.

Vol. 05 No. 15 | April 13, 1979

Download PDF Visit The Full Archive

Related Articles

Ceritinib Demonstrates 58% ORR, 7-month PFS in ALK+ NSCLC

March 28, 2014

Benefit Seen In Novel Drug That Treats Gleevec Resistance

April 29, 2005

Marc Lippman To Leave Georgetown For Michigan To Head Internal Medicine; Five Named To DCLG.

September 15, 2000

Dendreon Claims “Clear Hit” On Provenge, But Skeptics Await Data Presentation

April 17, 2009

U.S., Japan Establish Joint AIDS Panel

August 14, 1987

Conversation With The Cancer Letter: Wicha to Leave Director’s Job at UMich

November 8, 2013